Reading time is 2 mins


Hepatitis C is a serious disease that causes cirrhosis and liver cancer in the long term, said a Turkish professor of Infectious Diseases and Clinical Microbiology, who noted that the Hepatitis C virus, an insidious disease, leads to cirrhosis and liver cancer in the long term. Dr. “Patients should not disrupt their control for fear of the virus,” said.

Hepatitis is an inflammation of the liver in the simplest sense, and the most important cause is viruses, alcohol use, and various medications. There are different types of viruses (A, B, C, D and E) that cause Viral hepatitis. Hepatitis B, C and D usually cause chronic (long-term) infection, said a professor of Infectious Diseases and Clinical Microbiology. Dr. ‘ only 15-25 percent of people who are infected with the Hepatitis C virus and have acute hepatitis C can recover. In other patients, the disease unfortunately becomes chronic,’ he said, and gave the following information about it…


Many patients do not know how hepatitis C is transmitted to them. It is mainly transmitted by blood. In addition, Hepatitis C is transmitted by positive organ transplantation, by common use of old injectors (hemodialysis patients), sexually, although rare, by a toothbrush with blood on it, shaving materials, manicure-pedicure tools, piercing procedures, and rarely by a pregnant child with hepatitis C.


After an average incubation period of 6-7 weeks after transmission of the virus, the period called acute hepatitis C develops. Most patients have no symptoms. Deciduous complaints of patients muscle include: fever, weakness, fatigue, loss of appetite, joint or muscle pain, and jaundice. The disease becomes chronic in 75-80 percent of patients after 6 months. In patients with chronic hepatitis C may not have any symptoms. After 20-30 years, some patients develop cirrhosis and liver failure. If the disease turns into cirrhosis; symptoms such as swelling in the abdomen, easy bruising-bleeding in the body, thinning November muscles, jaundice, drowsiness, coma and bloody vomiting may develop. Hepatitis C is also one of the most important causes of liver cancer.


The diagnosis of the disease is made by a hepatitis C virus antibody test (anti‐HCV), which can be looked at in almost all hospitals and family health centers. Anti-HCV positivity does not always indicate that the person has chronic hepatitis C. Anti-HCV remains positive for life, even in a person who defeats the disease spontaneously or with the help of medication. The HCV-RNA test is evaluated to make the distinction. If HCV-RNA is negative, the person does not have hepatitis C infection. If it is positive, there is a hepatitis C infection, and this person should be treated.


The Covid – 19 pandemic disrupted health care, reducing access to routine Hepatitis C virus antibody screening, clinical care and treatment. Therefore, people were unaware of their disease status or patients could not go for a check-up. These people may develop advanced liver disease over time. In addition, individuals infected with the Hepatitis C virus can continue to unknowingly infect others. Therefore people; if they are in a risky group, if they suspect hepatitis, if they have been diagnosed in Turkey with hepatitis but have never started treatment or if they have disrupted their control during the pandemic, they should consult a doctor in Turkey without wasting time.


Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.


Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.


Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.


Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me